Cipla Ltd (CIPLA) — Announcement | 3 September 2026 (2 announcements)

3 September 2026 · BSE 🔴 High Importance Neutral

By StockFin Research Team•AI-Assisted Analysis•Source: BSE/NSE Filings

1Announcement🔴 High Importance Neutral📄 PDF

📢 Key Event

Cipla initiates shareholder and creditor notice for Inzpera merger under NCLT order

💡 Investor Takeaway

Shareholders and creditors must respond within 30 days or be deemed to have no objections to the merger.

Cipla announced that following an NCLT order dated 18 August 2026, it is sending notices to shareholders and unsecured creditors of the proposed merger with Inzpera Healthsciences Limited, allowing them 30 days to submit objections before the scheme is deemed approved. The notice is issued under Section 230 of the Companies Act and distributed via email and physical mail.

2Announcement🔴 High Importance Neutral📄 PDF

📢 Key Event

Cipla partners with Qilu for US biosimilar supply of Keytruda

💡 Investor Takeaway

The partnership expands Cipla's oncology portfolio and US market presence through a biosimilar collaboration.

Cipla announced an exclusive partnership with Qilu Pharmaceutical to license and supply a biosimilar version of Keytruda (pembrolizumab) in the United States, leveraging Cipla USA's commercial capabilities and Qilu's development and manufacturing strengths to expand access to oncology biologics.

📊 Stock Analysis — CIPLA ✨ Ask AI About This

About Cipla Ltd (CIPLA)

Healthcare · Pharmaceuticals · Listed on BSE

Market Cap: ₹1,09,059.12 CrP/E: 32.3ROE: 9.8%ROCE: 13.2%Div Yield: 0.96%

View full CIPLA stock details →

📡 Get AI alerts when CIPLA files next

Free • Daily 5 PM digest • Track filings, board meetings, and corporate actions

Track CIPLA — Free

💡 Ask AI about this filing

"When will the merger be completed?""What are the expected synergies from the Inzpera merger?""How will the merger affect Cipla's dividend policy?"

Ask AI Free →

📊 More CIPLA filings

🟡 Board Meeting — 28 September 2026Cipla announced a board meeting on October 27, 2026, to approve unaudited financial results for the ...
🔴 Corporate Action — 24 September 2026Cipla announced the allotment of 12,168 fully paid-up equity shares of INR 2 each under its ESOS 201...
🔴 Announcement — 22 September 2026Cipla announced that Global Head Supply Chain Venkata Sai Mungara will transition to Chief of Manufa...
🔴 Announcement — 18 September 2026Cipla announced it received an ESG rating of 68 from Niche, a SEBI-registered provider, communicated...
🔴 Announcement — 31 August 2026Cipla announced on August 31, 2026 that it signed an exclusive licensing agreement with SBP Group’s ...

See all CIPLA filings →

🔥 Also filed on 3 September 2026

517554NHC Foods LtdAnnual Report HINDCOMPOSHindustan Composites LtdAnnouncement 534796JUJHAR LOGISTICS LIMITEDAnnual Report 500388Shree Krishna Paper Mills & Industries LtdAnnual Report VSTLVibhor Steel Tubes LtdInsider Trading GAUDIUMIVFGaudium IVF and Women Health LtdAnnual Report

View all today's announcements →

Source: Stock Announcements. Analysis by StockFin.ai. For informational purposes only — not investment advice.

Editorial & Data Transparency Notice

This analysis was programmatically compiled using StockFin AI utilizing official regulatory disclosures from the BSE and NSE. Content is automatically synthesized and audited against public financial filings. StockFin.ai is an educational research platform and is NOT a SEBI-registered investment advisor or research analyst.

📡 Get AI alerts when CIPLA files new disclosures

Track CIPLA filings, board meetings, and corporate actions. Free email alerts at 5 PM.